Eckert & Ziegler Strahlen- und Medizintechnik Forecast, price target & analysts
Eckert & Ziegler Strahlen- und Medizintechnik Target price 2026 - Analyst rating & recommendation
Eckert & Ziegler Strahlen- und Medizintechnik Classifications & Recommendation:
Eckert & Ziegler Strahlen- und Medizintechnik Price Target
| Target Price | €22.13 |
| Price | €15.01 |
| Potential |
47.46%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Eckert & Ziegler Strahlen- und Medizintechnik 2027 .
The average Eckert & Ziegler Strahlen- und Medizintechnik target price is €22.13.
This is
47.46%
register free of charge
€25.20
67.89%
register free of charge
€17.98
19.77%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend Eckert & Ziegler Strahlen- und Medizintechnik to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Eckert & Ziegler Strahlen- und Medizintechnik stock has an average upside potential 2027 of
47.46%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million € | 295.85 | 320.78 |
| 20.22% | 8.43% | |
| EBITDA Margin | 23.73% | 28.64% |
| 18.13% | 20.68% | |
| Net Margin | 11.25% | 18.63% |
| 5.26% | 65.62% |
5 Analysts have issued a sales forecast Eckert & Ziegler Strahlen- und Medizintechnik 2025 . The average Eckert & Ziegler Strahlen- und Medizintechnik sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Eckert & Ziegler Strahlen- und Medizintechnik EBITDA forecast 2025. The average Eckert & Ziegler Strahlen- und Medizintechnik EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Eckert & Ziegler Strahlen- und Medizintechnik Analysts have issued a net profit forecast 2025. The average Eckert & Ziegler Strahlen- und Medizintechnik net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | 0.53 | 0.96 |
| 26.19% | 81.13% | |
| P/E | 15.97 | |
| EV/Sales | 2.74 |
5 Analysts have issued a Eckert & Ziegler Strahlen- und Medizintechnik forecast for earnings per share. The average Eckert & Ziegler Strahlen- und Medizintechnik EPS is
This results in the following potential growth metrics and future valuations:
Eckert & Ziegler Strahlen- und Medizintechnik...
Current Eckert & Ziegler Strahlen- und Medizintechnik Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Locked
➜
Locked
|
Locked | Nov 17 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Sep 11 2025 |
| HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
| HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
| HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | Dec 02 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG:
Locked
➜
Locked
|
Nov 17 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Sep 11 2025 |
|
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
Aug 11 2025 |
|
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
Apr 01 2025 |
|
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
Dec 02 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
